The American Psychiatric Association Foundation invites submissions for The Alexander Gralnick, M.D. Award for Research in Schizophrenia annually in the fall.
Named after the late Alexander Gralnick, M.D., the award acknowledges research achievements in the treatment of schizophrenia, emphasizing early diagnosis and treatment and psychosocial aspects of the disease process. Additional preference will be given to researchers working in a psychiatric facility. The amount of the award is $3,000.
The applicant should submit the following:
- A statement summarizing the nature of his or her research relevant to the award, emphasizing its internal consistency and scientific implications;
- A list of publications (or articles accepted for publication) relevant to the award;
- An up-to-date Curriculum Vitae; and
- An up-to-date bibliography.
The application may be emailed in PDF format to email@example.com using "Alexander Gralnick, M.D. Award application" as the subject line.
Contact Lindsey Fox, Director of Corporate and Community Relations with questions about the award or application process.
An expert committee in the field of schizophrenia research will confer the award. The award and lecture are presented at the Institute on Psychiatric Services (IPS) meetings in October. All applications will be acknowledged, but will not be returned. The award is based upon a bi-annual competition; resubmission is permitted and encouraged.
The American Psychiatric Association Foundation is a 501(C)(3) organization. An endowment for this award was provided by the Gralnick Foundation in memory of Dr. Alexander Gralnick's work and interest in the field of schizophrenia.